Duties & Responsibilities
- Ensuring that a local pharmacovigilance (PV) system is set up and maintained that is compliant with local legislation and global BI PV standards for assigned countries within the Regional Center Vienna (RCV) Region
- Contribute to the update and writing of Regional Operating Unit and local PV working instructions and procedures for countries within the RCV Region, in co-operation with related departments (Clinical Development, Medical Affairs, Quality Management) and ensure implementation of these in daily activities
- Provide support in the management of PV responsibilities for local activities such as clinical trials, non-interventional studies and compassionate use programs, in co-operation with related departments (Clinical Development/Medical Affairs)
- Preparation and conduct of trainings on safety matters for Boehringer Ingelheim staff at the Regional Center Vienna site and in the RCV region, as defined
- Co-operation with license partners regarding safety matters: overview and maintenance of Pharmacovigilance Agreements
- Interface with corporate departments, RCV departments and countries in the RCV region
- Contribution to quality management and PV reporting compliance within the RCV Region
- University degree, preferably in life sciences
- Knowledge of EU/international regulations/guidelines concerning drug development and pharmacovigilance of human drugs
- Proactive and assertive attitude
- Strong planning and time management skills
- Strong communication and team-work skills
- Excellent command of English language
Our CultureBoehringer Ingelheim is one of the world's 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, Boehringer Ingelheim operates globally through 145 affiliates and a total of some 50,000 employees. The focus of the family-owned company, founded in 1885, is on researching, developing, manufacturing and marketing new medications of high therapeutic value for human and veterinary medicine. In 2015, Boehringer Ingelheim achieved net sales of about 14.8 billion euros. R&D expenditure corresponds to 20.3 per cent of net sales.
Boehringer Ingelheim is an equal opportunity employer who takes pride in maintaining a diverse and inclusive workplace. We embrace all aspects of diversity and inclusion which benefit our employees, patients and communities.